Abstract:Objective The incidence of acute pulmonary injury occurred after cardiopulmonary bypass for fallot tetrad has been high. The severity of pulmonary ischemia-reperfusion has been found to be reduced with ulinastatin (UTI) in the animal models and clinical practice. We evaluated the effect of pulmonary artery perfusion with a hypothermic protective solution containing ulinastatin on the inflammatory response in the lung during cardiopulmonary bypass. Methods 30 children with tetralogy of Fallot (TOF) were randomly assigned into control group and protective group, 15 cases in each group. Patients would be excluded if they had signs of infections, such as the white blood cell count was over 12000 per microliter, the temperature was above 38 centi-degree and the c-reaction protein was more than 8 mg/L. Operation with routine approaches was performed in the control group and the pulmonary artery was infused with 4℃ protective solution in the protective group while the heart stoped beating. Plasma tumor necrosis factor α (TNF-α) 、CD11b and Myeloperoxidase (MPO) were measured intraoperatively and postoperatively. Blood gas、pulmonary function and clinic index of the patients were also monitored. Results The level of TNF-α was lower in the protective group as compared with that in the control group immediately and 3 hours after closing the sternum [(11.15±2.47) pg/ml vs. (14.21 ±5.55) pg/ml, P<0.05; (12.01 ±2.69) pg/ml vs. (15.94 ±4.86)pg/ml,P <0.01]. The MFI of CD11b was lower in the protective group as compared with that in the control group at 3 and 6 hoursafter closing the sternum (126.23±36.05 vs. 156.98±48.34, P<0.05; 137.27±38.85 vs. 173.27±67.43, P<0.05). The level of MPO was lower in protective group as compared with that in the control group at 3 hours, 6 hours and 24hours after closing the sternum [(156.52±17.57)U/L vs.(178.45±35.68)U/L, P<0.05; (178.28±23.63) U/L vs.(224.66±49.66)U/L, P<0.01;(130.52±57.50)U/L vs. (96.50±14.49)U/L, P<0.05]. The duration of mechanical ventilation was significantly shorter in the protective group than that in the control group (17.60±6.39 vs. 23.70±8.51,P<0.05). Alveolar-arterial oxygen pressure difference (A-aDO2, calculated as [FiO2×713-5/4×PaCO2]-PaO2) in the protective group was less than that in the control group at 3 and 6 hours after closing the sternum [(120.92±33.08)mm Hg vs. (145.52±39.38)mmHg, P<0.05;(74.76±40.16)mm Hg vs. (112.50±44.16)mmHg, P<0.01]. Dynamic compliance (Cdyn) in protective group was lower than that in control group at 3 and 6 hours after closing the sternum [(0.59±0.11)ml·cmH2O-1·kg-1 vs. (0.46±0.17)ml·cmH2O-1·kg-1, P<0.05;(0.67±0.09)ml·cmH2O-1·kg-1vs. (0.53±0.18)ml·cmH2O-1·kg-1,P<0.05). Conclusion Perfusion with hypothermic protective solution containing UTI to the pulmonary artery during cardiopulmonary bypass may reduce the inflammatory responses substantially in the lung after bypass and had a role in the lung protection.

Heme oxygenase expression in myocardium before and after cardiopulmonary bypass

Role of Heme Oxygenase- 1 in Cardioprotection Against Anoxia/reoxygenation Induced Injury and Its Mechanisms

Changes in transforming growth factor-beta mRNA expressionin the lung in a dog model of cardiopulmonary bypass-induced acute lung injury

Involvement of COX-2 in Antagonism to Heme Oxygenase-1 on Cardioprotection from Anoxia/reoxygenation Induced Injury in Rats

Involvement of GC in Effect of Heme Oxygenase-1 on Cardioprotection from Ischemia/reperfusion Induced injury

Effects of Pulmonary Protective Solution Involved Ulinastatin on Lung Function after Cardioopulmonary Bypass

[Effect of Heme Oxygenase-1 on Hydrogen Peroxide Induced Hypo-Responses in Vascular Contraction].

The Protective Effects of ATP-sensitive Potassium Channel Participating in Activation of Heme Oxygenase 1 (HO-1) on Ischemia-Reperfusion Injury in Heart

The effect of cardiopulmonary bypass on the activation of peripheral T lymphocytes in children under open - heart operation

The protective role of hypothermic protective solution during surgey for the tetralogy of Fallot

The effect of cardiopulmonary bypass on monocyte HLA-DR expression

[Effect of Cardiopulmonary Bypass on CD11/CD18 Expression of Neutrophils in Children Undergoing Cardiac Surgery].

Hypoxemia Induces Expression of Heme Oxygenase-1 and Heme Oxygenase-2 Proteins in the Mouse Myocardium.

Expression of Adhesion Molecule of Myocardial Tissue During Cardiopulmonary Bypass and Influence of Aprotinin

Variations of placental growth factor and its receptor Fit-1 before and after cardiopulmonary bypass

Heme oxygenase-1 induction protects the heart and modulates cellular and extracellular remodelling after myocardial infarction in rats

Influence of beating and arrested heart surgery with cardiopulmonary bypass on prostaglandins

Abstract 9534: Expression of Heme Oxygenase-1 in Cardiac Stem Cells Enhances the Efficacy of Cell Therapy for Attenuating Left Ventricular Dysfunction and Remodeling After Myocardial Infarction

[Comparison and Correlative Analysis of Pulmonary Function Markers after Extracorporeal Circulation].

[Preventive Effects and Mechanism of Heme Oxygenase-1 Activation on Acute Respiratory Distress Syndrome in Rats].

Increased heme oxygenase-1 expression in infarcted rat hearts following human bone marrow mesenchymal cell transplantation.